SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-098806
Filing Date
2017-03-28
Accepted
2017-03-28 08:31:33
Documents
4
Period of Report
2017-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d339344d8k.htm 8-K 17090
2 EX-10.1 d339344dex101.htm EX-10.1 11090
3 EX-99.1 d339344dex991.htm EX-99.1 5388
4 GRAPHIC g339344g44a58.jpg GRAPHIC 1772
  Complete submission text file 0001193125-17-098806.txt   37396
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 17716877
SIC: 2834 Pharmaceutical Preparations